MLB Clears Dr. Neal ElAttrache in Doping Case Involving UFC Star

The Major League Baseball (MLB) has cleared Dr. Neal ElAttrache, the team physician for the Los Angeles Dodgers, of any malpractice concerning his support for the use of performance-enhancing drugs by UFC star Conor McGregor. The incident arose when McGregor suffered a severe leg injury.

In a statement released on Tuesday, the MLB commissioner’s office noted that they interviewed Dr. ElAttrache the previous week. He was found to have ‘answered our questions thoroughly’. The investigation included a review of relevant records, and the commissioner’s office concluded, ‘we do not have any concerns regarding Dr. ElAttrache’s treatment of MLB players or his adherence to the sport’s anti-doping program.’

The office confirmed, ‘We consider this matter closed.’ Dr. ElAttrache has not commented on the statement’s release.

Apart from his affiliation with the Dodgers, Dr. ElAttrache is the chief medical officer for the Los Angeles Rams and is regarded among the top sports physicians. Over the last decade, he has been involved in the care of 18 out of 29 Cy Young or Most Valuable Player award-winning baseball players, including notable figures like Bryce Harper and Shohei Ohtani.

The swift resolution to clear Dr. ElAttrache followed a report by The New York Times that highlighted his letter of support for a special exemption to allow McGregor the use of banned substances during his recovery from a leg fracture. This exemption was reportedly aimed at exploiting a loophole in the anti-doping regulations.

Sports doctors, anti-doping authorities, and trauma surgeons were unfamiliar with any similar exemptions being granted, and Dr. ElAttrache’s support for the exemption was notable.

MLB indicated its commitment to due diligence by investigating Dr. ElAttrache’s involvement. This was to ensure he supported no similar conduct within baseball.

The National Football League has not commented on whether it will pursue its own investigation into Dr. ElAttrache’s actions.

Michael S. Schmidt, an investigative reporter for The New York Times, has been tracking federal investigations, particularly those with high profiles.